Franz KB. A functional biological marker is needed for diagnosing magnesium deficiency. J Am Coll Nutr. 2004;23:738S-741S.
Shils ME. Magnesium. In: Shils ME, Olson JA, Shike M, et al., eds. Modern nutrition in health and disease. 9th ed. New York, NY: Lippincott Williams & Wilkins; 1999:169-192.
Atsmon J, Dolev E. Drug-induced hypomagnesaemia: scope and management. Drug Saf. 2005;28:763-788.
Tong GM, Rude RK. Magnesium deficiency in critical illness. J Intensive Care Med. 2005;20:3-17.
1. Franz KB. A functional biological marker is needed for diagnosing magnesium deficiency. J Am Coll Nutr. 2004;23:738S-741S.
2. Shils ME. Magnesium. In: Shils ME, Olson JA, Shike M, et al., eds. Modern nutrition in health and disease. 9th ed. New York, NY: Lippincott Williams & Wilkins; 1999:169-192.
3. Schlingmann KP, Weber S, Peters M, et al. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet. 2002;31:166-170.
4. Nadler MJ, Hermosura MC, Inabe K, et al. LTRPC7 is a Mg.ATP-regulated divalent cation channel required for cell viability. Nature. 2001;411:590-595.
5. Wester PO. Magnesium. Am J Clin Nutr. 1987;45(5 Suppl):1305-1312.
6. Groenestege WM, Hoenderop JG, van den Heuvel L, et al. The epithelial Mg2+ channel transient receptor potential melastatin 6 is regulated by dietary Mg2+ content and estrogens. J Am Soc Nephrol. 2006;17:1035-1043.
7. Cao G, Hoenderop JG, Bindels RJ. Insight into the molecular regulation of the epithelial magnesium channel TRPM6. Curr Opin Nephrol Hypertens. 2008;17:373-378.
8. Quamme GA, de Rouffignac C. Epithelial magnesium transport and regulation by the kidney. Front Biosci. 2000;5:D694-D711.
9. Romani AM, Scarpa A. Regulation of cellular magnesium. Front Biosci. 2000;5:D720-D734.
10. Gunther T. Functional compartmentation of intracellular magnesium. Magnesium. 1986;5:53-59.
11. Romani A, Scarpa A. Regulation of cell magnesium. Arch Biochem Biophys. 1992;298:1-12.
12. Atsmon J, Dolev E. Drug-induced hypomagnesaemia: scope and management. Drug Saf. 2005;28:763-788.
13. Cundy T, Dissanayake A. Severe hypomagnesaemia in long-term users of proton-pump inhibitors. Clin Endocrinol (Oxf). 2008;69:338-341.
14. Lameris AL, Hess MW, van Krujisbergen I, et al. Omeprazole enhances the colonic expression of the Mg2+ transporter TRPM6. Pflugers Arch. 2013;465:1613-1620.
15. US Food and Drug Administration. FDA drug safety communication: low magnesium levels can be associated with long-term use of proton pump inhibitor drugs (PPIs). March 2011. https://www.fda.gov/ (last accessed 29 August 2017).
16. Belani CP, Schreeder MT, Steis RG, et al. Cetuximab in combination with carboplatin and docetaxel for patients with metastatic or advanced-stage nonsmall cell lung cancer: a multicenter phase 2 study. Cancer. 2008;113:2512-2517.
17. Barton CH, Vaziri ND, Martin DC, et al. Hypomagnesemia and renal magnesium wasting in renal transplant recipients receiving cyclosporine. Am J Med. 1987;83:693-699.
19. Wolf FI, Cittadini AR, Maier JA. Magnesium and tumors: ally or foe? Cancer Treat Rev. 2009;35:378-382.
20. Pironi L, Malucelli E, Guidetti M, et al. The complex relationship between magnesium and serum parathyroid hormone: a study in patients with chronic intestinal failure. Magnes Res. 2009;22:37-43.
21. James MF, Cork RC, Harlen GM, et al. Interactions of adrenaline and magnesium on the cardiovascular system of the baboon. Magnesium. 1988;7:37-43.
22. Hampson G, Konrad MA, Scoble J. Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis (FHHNC): compound heterozygous mutation in the claudin 16 (CLDN16) gene. BMC Nephrol. 2008;9:12.
23. Sha Q, Pearson W, Burcea LC, et al. Human FXYD2 G41R mutation responsible for renal hypomagnesemia behaves as an inward-rectifying cation channel. Am J Physiol Renal Physiol. 2008;295:F91-F99.
24. Nijenhuis T, Vallon V, van der Kemp AW, et al. Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest. 2005;115:1651-1658.
25. Naderi AS, Reilly RF Jr. Hereditary etiologies of hypomagnesemia. Nature Clin Pract Nephrol. 2008;4:80-89.
26. Vezzoli G, Soldati L, Gambaro G. Roles of calcium-sensing receptor (CaSR) in renal mineral ion transport. Curr Pharm Biotechnol. 2009;10:302-310.
27. Sukonpan K, Phupong V. Serum calcium and serum magnesium in normal and preeclamptic pregnancy. Arch Gynecol Obstet. 2005;273:12-16.
28. Kisters K, Niedner W, Fafera I, et al. Plasma and intracellular Mg2+ concentrations in pre-eclampsia. J Hypertens. 1990;8:303-306.
29. Kaufman ES. Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome. Heart Rhythm 2009;6(8 suppl):S51-S55.
30. Tong GM, Rude RK. Magnesium deficiency in critical illness. J Intensive Care Med. 2005;20:3-17.
31. Rob PM, Dick K, Bley N, et al. Can one really measure magnesium deficiency using the short-term magnesium loading test? J Intern Med. 1999;246:373-378.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台